Non-eosinophilic airway hyper-reactivity in mice, induced by IFN-γ producing CD4+ and CD8+ lung T cells, is responsive to steroid treatment

Scandinavian Journal of Immunology

Volumn 80, Issue 5, 2014, Pages 327-338

  Stein, J ^a   Maxeiner, J H ^a   Montermann, E ^a   Hohn Y ^a   Raker, V ^a   Taube, C ^a   Sudowe, S ^a   Reske Kunz, A B ^a  

^a JOHANNES GUTENBERG UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BETA GALACTOSIDASE; DEXAMETHASONE; DNA; GAMMA INTERFERON;

ANIMAL; ASTHMA; BAGG ALBINO MOUSE; BIOLISTIC TRANSFORMATION; BIOSYNTHESIS; CYTOLOGY; CYTOTOXIC T LYMPHOCYTE; DISEASE MODEL; EOSINOPHIL; FEMALE; GENETICS; GOBLET CELL; IMMUNOLOGY; LUNG; LUNG LAVAGE; LYMPHOCYTE ACTIVATION; LYMPHOCYTE DEPLETION; METABOLISM; MOUSE; NEUTROPHIL; NEUTROPHIL CHEMOTAXIS; PATHOLOGY; TH1 CELL; TH17 CELL; TH2 CELL;

ANIMALS; ASTHMA; BETA-GALACTOSIDASE; BIOLISTICS; BRONCHOALVEOLAR LAVAGE FLUID; DEXAMETHASONE; DISEASE MODELS, ANIMAL; DNA; EOSINOPHILS; FEMALE; GOBLET CELLS; INTERFERON-GAMMA; LUNG; LYMPHOCYTE ACTIVATION; LYMPHOCYTE DEPLETION; MICE; MICE, INBRED BALB C; NEUTROPHIL INFILTRATION; NEUTROPHILS; T-LYMPHOCYTES, CYTOTOXIC; TH1 CELLS; TH17 CELLS; TH2 CELLS;

EID: 84911481328     PISSN: 03009475     EISSN: 13653083     Source Type: Journal    
DOI: 10.1111/sji.12217     Document Type: Article

References (58)

1. Holgate S, Bisgaard H, Bjermer L et al. The Brussels Declaration: the need for change in asthma management. Eur Respir J 2008;32:1433-42.
2. Wenzel SE. Asthma phenotypes: the evolution from clinical to molecular approaches. Nat Med 2012;18:716-25.
3. Mukherjee AB, Zhang Z. Allergic asthma: influence of genetic and environmental factors. J Biol Chem 2011;286:32883-9.
4. McGrath KW, Icitovic N, Boushey HA et al. Asthma Clinical Research Network of the National Heart, Lung, and Blood Institute. A large subgroup of mild-to-moderate asthma is persistently noneosinophilic. Am J Respir Crit Care Med 2012;185:612-9.
5. Wenzel SE, Schwartz LB, Langmack EL et al. Evidence that severe asthma can be divided pathologically into two inflammatory subtypes with distinct physiologic and clinical characteristics. Am J Respir Crit Care Med 1999;160:1001-8.
6. Simpson JL, Scott R, Boyle MJ, Gibson PG. Inflammatory subtypes in asthma: assessment and identification using induced sputum. Respirology 2006;11:54-61.
7. Walsh GM, Sexton DW, Blaylock MG. Corticosteroids, eosinophils and bronchial epithelial cells: new insights into the resolution of inflammation in asthma. J Endocrinol 2003;178:37-43.
8. Basyigit I, Yildiz F, Ozkara SK, Boyaci H, Ilgazli A. Inhaled corticosteroid effects both eosinophilic and non-eosinophilic inflammation in asthmatic patients. Mediators Inflamm 2004;13:285-91.
9. Cowan DC, Cowan JO, Palmay R, Williamson A, Taylor DR. Effects of steroid therapy on inflammatory cell subtypes in asthma. Thorax 2010;65:384-90.
10. Green RH, Brightling CE, Woltmann G, Parker D, Wardlaw AJ, Pavord ID. Analysis of induced sputum in adults with asthma: identification of subgroup with isolated sputum neutrophilia and poor response to inhaled corticosteroids. Thorax 2002;57:875-9.
11. Berry M, Morgan A, Shaw DE et al. Pathological features and inhaled corticosteroid response of eosinophilic and non-eosinophilic asthma. Thorax 2007;62:1043-9.
12. Nials AT, Uddin S. Mouse models of allergic asthma: acute and chronic allergen challenge. Dis Model Mech 2008;1:213-20.
13. Conrad ML, Yildirim AO, Sonar SS et al. Comparison of adjuvant and adjuvant-free murine experimental asthma models. Clin Exp Allergy 2009;39:1246-54.
14. Takaoka A, Tanaka Y, Tsuji T et al. A critical role for mouse CXC chemokine(s) in pulmonary neutrophilia during Th type 1-dependent airway inflammation. J Immunol 2001;167:2349-53.
15. Cui J, Pazdziorko S, Miyashiro JS et al. TH1-mediated airway hyperresponsiveness independent of neutrophilic inflammation. J Allergy Clin Immunol 2005;115:309-15.
16. McKinley L, Alcorn JF, Peterson A et al. TH17 cells mediate steroid-resistant airway inflammation and airway hyperresponsiveness in mice. J Immunol 2008;181:4089-97.
17. Yang M, Kumar RK, Foster PS. Pathogenesis of steroid-resistant airway hyperresponsiveness: interaction between IFN-γ and TLR4/MyD88 pathways. J Immunol 2009;182:5107-15.
18. Sudowe S, Ludwig-Portugall I, Montermann E, Ross R, Reske-Kunz AB. Transcriptional targeting of dendritic cells in gene gun-mediated DNA immunization favors the induction of type 1 immune responses. Mol Ther 2003;8:567-75.
19. Sudowe S, Dominitzki S, Montermann E, Bros M, Grabbe S, Reske-Kunz AB. Uptake and presentation of exogenous antigen and presentation of endogenously produced antigen by skin dendritic cells represent equivalent pathways for the priming of cellular immune responses following biolistic DNA immunization. Immunology 2009;128:e193-205.
20. Zindler E, Gehrke N, Luft C et al. Divergent effects of biolistic gene transfer in a mouse model of allergic airway inflammation. Am J Respir Cell Mol Biol 2008;38:38-46.
21. Ross R, Sudowe S, Beisner J et al. Transcriptional targeting of dendritic cells for gene therapy using the promoter of the cytoskeletal protein fascin. Gene Ther 2003;10:1035-40.
22. Raz E, Tighe H, Sato Y et al. Preferential induction of a Th1 immune response and inhibition of specific IgE antibody formation by plasmid DNA immunization. Proc Natl Acad Sci USA 1996;93:5141-5.
23. Hochreiter R, Hartl A, Freund J, Valenta R, Ferreira F, Thalhamer J. The influence of CpG motifs on a protein or DNA-based Th2-type immune response against major pollen allergens Bet v 1a, Phl p 2 and Escherichia coli-derived β-galactosidase. Int Arch Allergy Immunol 2001;124:406-10.
24. Scheiblhofer S, Gabler M, Leitner WW et al. Inhibition of type I allergic responses with nanogram doses of replicon-based DNA vaccines. Allergy 2006;61:828-35.
25. Raker V, Maxeiner J, Reske-Kunz AB, Sudowe S. Efficiency of biolistic DNA vaccination in experimental type I allergy. Methods Mol Biol 2013;940:357-70.
26. Sudowe S, Montermann E, Steitz J, Tüting T, Knop J, Reske-Kunz AB. Efficacy of recombinant adenovirus as vector for allergen gene therapy in a mouse model of type I allergy. Gene Ther 2002;9:147-56.
27. + T cells in the draining lymph nodes and lung during allergic airway inflammation in vivo. J Immunol 2008;181:1917-26.
28. Fleming TJ, Fleming ML, Malek TR. Selective expression of Ly-6G on myeloid lineage cells in mouse bone marrow. RB6-8C5 mAb to granulocyte-differentiation antigen (Gr-1) detects members of the Ly-6 family. J Immunol 1993;151:2399-408.
29. Lopez AF, Strath M, Sanderson CJ. Differentiation antigens on mouse eosinophils and neutrophils identified by monoclonal antibodies. Br J Haematol 1984;57:489-94.
30. Dialynas DP, Wilde DB, Marrack P et al. Characterization of the murine antigenic determinant, designated L3T4a, recognized by monoclonal antibody GK1.5: expression of L3T4a by functional T cell clones appears to correlate primarily with class II MHC antigen-reactivity. Immunol Rev 1983;74:29-56.
31. Ledbetter JA, Herzenberg LA. Xenogeneic monoclonal antibodies to mouse lymphoid differentiation antigens. Immunol Rev 1979;47:63-90.
32. Brown CR, Blaho VA, Loiacoco CM. Treatment of mice with the neutrophil-depleting antibody RB6-8C5 results in early development of experimental lyme arthritis via the recruitment of Gr-1 polymorphonuclear leukocyte-like cells. Infect Immun 2004;72:4956-65.
33. Xu X, Zhang D, Zhang H et al. Neutrophil histamine contributes to inflammation in mycoplasma pneumonia. J Exp Med 2006;203:2907-17.
34. Xiao H, Heeringa P, Liu Z et al. The role of neutrophils in the induction of glomerulonephritis by anti-myeloperoxidase antibodies. Am J Pathol 2005;167:39-45.
35. McFarlane E, Perez C, Charmoy M et al. Neutrophils contribute to development of a protective immune response during onset of infection with Leishmania donovani. Infect Immun 2008;76:532-41.
36. + T cell subsets by the administration of anti-Gr-1 monoclonal antibody in vivo. Cell Immunol 2003;224:98-105.
37. Daley JM, Thomay AA, Connolly MD, Reichner JS, Albina JE. Use of Ly6G-specific monoclonal antibody to deplete neutrophils in mice. J Leukoc Biol 2008;83:64-70.
38. + cell populations during microbial infection. Immunol Res 2008;40:35-48.
39. Hessel EM, Van Oosterhout AJ, Van Ark I et al. Development of airway hyperresponsiveness is dependent on interferon-gamma and independent of eosinophil infiltration. Am J Respir Cell Mol Biol 1997;16:325-34.
40. The National Heart, Lung, and Blood Institute Health Information Center. Expert Panel Report 3: Guidelines for the diagnosis and management of asthma. 2007; [cited 2012 Dec 28]; available from: http://www.nhlbi.nih.gov/guidelines/asthma/asthgdln.pdf.
41. Creed TJ, Lee RW, Newcomb PV, di Mambro AJ, Raju M, Dayan CM. The effects of cytokines on suppression of lymphocyte proliferation by dexamethasone. J Immunol 2009;183:164-71.
42. Melis M, Siena L, Pace E et al. Fluticasone induces apoptosis in peripheral T-lymphocytes: a comparison between asthmatic and normal subjects. Eur Respir J 2002;19:257-66.
43. Liberman AC, Druker J, Garcia FA, Holsboer F, Arzt E. Intracellular molecular signaling. Basis for specificity to glucocorticoid anti-inflammatory actions. Ann N Y Acad Sci 2009;1153:6-13.
44. Druilhe A, Létuvé S, Pretolani M. Glucocorticoid-induced apoptosis in human eosinophils: mechanisms of action. Apoptosis 2003;8:481-95.
45. Trifilieff A, El-Hashim A, Bertrand C. Time course of inflammatory and remodelling events in a murine model of asthma: effect of steroid treatment. Am J Physiol Lung Cell Mol Physiol 2000;279:L1120-8.
46. Eum SY, Maghni K, Hamid Q et al. Inhibition of allergic airways inflammation and airway hyperresponsiveness in mice by dexamethasone: role of eosinophils, IL-5, eotaxin, and IL-13. J Allergy Clin Immunol 2003;111:1049-61.
47. Quint JK, Wedzicha JA. The neutrophil in chronic obstructive pulmonary disease. J Allergy Clin Immunol 2007;119:1065-71.
48. Tubby C, Harrison T, Todd I, Fairclough L. Immunological basis of reversible and fixed airways disease. Clin Sci 2011;121:285-96.
49. Barnes PJ. Glucocorticosteroids: current and future directions. Br J Pharmacol 2011;163:29-43.
50. Sivertson KL, Seeds MC, Long DL, Peachman KK, Bass DA. The differential effect of dexamethasone on granulocyte apoptosis involves stabilization of Mcl-1L in neutrophils but not in eosinophils. Cell Immunol 2007;246:34-45.
51. + T lymphocyte is a site of steroid resistance in asthma. Q J Med 1998;91:567-72.
52. Kaur M, Smyth LJ, Cadden P et al. T lymphocyte insensitivity to corticosteroids in chronic obstructive pulmonary disease. Respir Res 2010;13:20.
53. Taube C, Nick JA, Siegmund B et al. Inhibition of early airway neutrophilia does not affect development of airway hyperresponsiveness. Am J Respir Cell Mol Biol 2004;30:837-43.
54. Li JJ, Wang W, Baines KJ et al. IL-27/IFN-γ induce MyD88-dependent steroid-resistant airway hyperresponsiveness by inhibiting glucocorticoid signaling in macrophages. J Immunol 2010;185:4401-9.
55. Ano S, Morishima Y, Ishii Y et al. Transcription factors GATA-3 and RORγt are important for determining the phenotype of allergic airway inflammation in a murine model of asthma. J Immunol 2013;190:1056-65.
56. Alcorn JF, Crowe CR, Kolls JK. TH17 cells in asthma and COPD. Annu Rev Physiol 2010;72:495-516.
57. Gibson PG, Simpson JL, Saltos N. Heterogeneity of airway inflammation in persistent asthma: evidence of neutrophilic inflammation and increased sputum interleukin-8. Chest 2001;119:1329-36.
58. Godon P, Boulet LP, Malo JL, Cartier A, Lemière C. Assessment and evaluation of symptomatic steroid-naïve asthmatics without sputum eosinophilia and their response to inhaled corticosteroids. Eur Respir 2002;20:1364-9.